Basit öğe kaydını göster

dc.contributor.authorCoskun, Ugur
dc.contributor.authorTONYALI, Onder
dc.contributor.authorKara, HASAN VOLKAN
dc.contributor.authorBALVAN, Ozlem
dc.contributor.authorEREN, Tulay
dc.contributor.authorHELVACI, Kaan
dc.contributor.authorBerk, Veli
dc.contributor.authorDEMIRCI, Umut
dc.contributor.authorOzturk, Selcuk Cemil
dc.contributor.authorDOGAN, Erkan
dc.contributor.authorCETIN, Bulent
dc.contributor.authorKucukoner, Mehmet
dc.contributor.authorTUFAN, Gulnihal
dc.contributor.authorOztop, Ilhan
dc.contributor.authorGUMUS, Mahmut
dc.contributor.authorUner, Aytug
dc.contributor.authorTURAN, Nedim
dc.contributor.authorBenekli, Mustafa
dc.contributor.authorDANE, FAYSAL
dc.contributor.authorOzet, Ahmet
dc.contributor.authorBuyukberber, Suleyman
dc.contributor.authorUnal, Olcun Umit
dc.contributor.authorTastekin, Didem
dc.contributor.authorKOCA, Dogan
dc.date.accessioned2021-03-04T12:07:23Z
dc.date.available2021-03-04T12:07:23Z
dc.date.issued2014
dc.identifier.citationTURAN N., Benekli M., DANE F., Unal O. U. , Kara H. V. , KOCA D., BALVAN O., EREN T., Tastekin D., HELVACI K., et al., "Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.", Thoracic cancer, cilt.5, sa.5, ss.398-404, 2014
dc.identifier.issn1759-7706
dc.identifier.otherav_75c711b8-2081-45a0-979d-40f07c1b6e2c
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/80892
dc.identifier.urihttps://doi.org/10.1111/1759-7714.12107
dc.description.abstractIntroduction: We investigated the impact of modern chemotherapy regimens and bevacizumab following pulmonary metastasectomy (PM) from metastatic colorectal cancer (CRC).
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectONKOLOJİ
dc.subjectGöğüs Hastalıkları ve Allerji
dc.subjectKlinik Tıp (MED)
dc.subjectSOLUNUM SİSTEMİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.titleAdjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.
dc.typeMakale
dc.relation.journalThoracic cancer
dc.contributor.department, ,
dc.identifier.volume5
dc.identifier.issue5
dc.identifier.startpage398
dc.identifier.endpage404
dc.contributor.firstauthorID100464


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster